Catalyst Clinical Research
  • Catalyst Flex
  • Catalyst Oncology
  • About Us
    • Our People
    • Our Purpose
    • Our Partners
    • Our Board
    • Our Events
    • Our News
  • Contact Us
  • Careers
Select Page
Expanded Global Oncology, Functional and Resourcing Services Launched by Catalyst Clinical Research

Expanded Global Oncology, Functional and Resourcing Services Launched by Catalyst Clinical Research

Jan 18, 2021 | Press Release

Wilmington, NC, 18 January 2021 – Evolved from over 15 years serving the biopharma industry, Catalyst Clinical Research formally launched two customized clinical service solutions in January — Catalyst Oncology and Catalyst Flex — to strengthen and expand the CRO’s...
Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle

Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle

Dec 3, 2020 | Press Release

Raleigh, NC, 4 December 2020 – Catalyst Clinical Research has ranked number nine on the Triangle Business Journal’s (TBJ) list of fastest 50 growing companies for 2020, a designation that salutes the fastest-growing privately held companies in the Research Triangle...
Catalyst Concludes Acquisition of Acumen Healthcare Solutions: Bolsters Database Expertise, Positions Proprietary ‘Flex’ for Future Growth

Catalyst Concludes Acquisition of Acumen Healthcare Solutions: Bolsters Database Expertise, Positions Proprietary ‘Flex’ for Future Growth

Nov 18, 2020 | Press Release

Wilmington, NC, 18 November 2020 – Catalyst Clinical Research announced today the company has completed the acquisition of Acumen Healthcare Solutions (AHS), a data management software and services company headquartered in Plymouth, Minnesota. Catalyst CEO Nick Dyer...
Catalyst Named to 2020 Inc. 5000 List of Fastest-Growing Private Companies

Catalyst Named to 2020 Inc. 5000 List of Fastest-Growing Private Companies

Aug 12, 2020 | Press Release

­­­Wilmington, NC, 12 August 2020 – For the first time, Wilmington-headquartered Catalyst Clinical Research appears on the Inc. 5000 list of fastest-growing private companies in America. Catalyst ranked 1235 on the list. Recognition on the Inc. 5000 list echoes...
Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO

Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO

Aug 5, 2020 | Press Release

Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged with Ce3, Inc. to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services...
Catalyst Hires VP, Oncology Drug Development to Accelerate Growth and Oncology Services Offerings

Catalyst Hires VP, Oncology Drug Development to Accelerate Growth and Oncology Services Offerings

Jun 11, 2020 | Press Release

Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and global resourcing organization, announced the hiring of Andrew Zupnick, PhD as Vice President of Oncology Drug Development. Dr. Zupnick will be...
« Older Entries

Recent Posts

  • Study Builds at Pandemic Speed: The Evolving Global Landscape of Clinical Trials
  • Clinical Trial Flexibility and Customization Needs that are Required by Biotechs and Next Generation Therapies
  • Expanded Global Oncology, Functional and Resourcing Services Launched by Catalyst Clinical Research
  • 10 Tips to Avoid COVID-19 While Traveling
  • Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle

Categories

  • Article
  • Infographic
  • Press Release
  • Uncategorized
  • Webinar
  • White Paper

Archives

  • Clinical Research Solutions
  • Functional Expertise
  • About Us
  • Contact Us
  • Careers
  • Facebook
  • Twitter
  • Google
Privacy Policy
We use cookies to ensure that we give you the best experience on our website.Got itPrivacy policy